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Ceramide and more complex sphingolipids constitute a
diverse group of lipids that serve important roles as structural
entities of biological membranes and as regulators of cellular
growth, differentiation, and development. Thus, ceramides are
vital players in numerous diseases including metabolic and car-
diovascular diseases, as well as neurological disorders. Here we
show that acyl-coenzyme A-binding protein (ACBP) potently
facilitates very-long acyl chain ceramide synthesis. ACBP
increases the activity of ceramide synthase 2 (CerS2) by more
than 2-fold and CerS3 activity by 7-fold. ACBP binds very-long-
chain acyl-CoA esters, which is required for its ability to stimu-
late CerS activity. We also show that high-speed liver cytosol
from wild-type mice activates CerS3 activity, whereas cytosol
from ACBP knock-out mice does not. Consistently, CerS2 and
CerS3 activities are significantly reduced in the testes of ACBP/
mice, concomitant with a significant reduction in long- and very-
long-chainceramide levels. Importantly,weshowthatACBPinter-
acts with CerS2 andCerS3. Our data uncover a novelmode of reg-
ulationof very-long acyl chain ceramide synthesis byACBP,which
we anticipate is of crucial importance in understanding the regula-
tion of ceramidemetabolism in pathogenesis.
Sphingolipids (SLs),4 and in particular ceramides, mediate a
number of cellular effects (1, 2) including insulin resistance and
are among the most deleterious lipids that perturb pancreatic
-cell function, vascular reactivity, andmitochondrial metabo-
lism, which underlie the development of diabetes, obesity, and
cardiovascular disease (3–5). Importantly, inhibition of cer-
amide synthesis ameliorates many metabolic disorders in
rodents (5). The ceramide N-acyl chain length significantly
impacts the function of ceramides (6). For instance, ablation of
ceramide synthase (CerS) 2, which catalyzes the formation of
very-long (C22–24) acyl chain ceramides, results in hepatic
insulin resistance inmice (7). Despite increased appreciation of
the importance of ceramides, little information is available to
allow delineation of the mechanism(s) of regulation of ceramide
synthesis. Six CerS isoforms exist in mammals, each synthesizing
ceramides with a specific acyl chain length (8). Thus, we only
have limited knowledge about the structure and function of
the CerS isoforms; however, it is known that the active site
resides in a sequence of 150 residues within the Tram-Lag-
CLN8 domain (9) and that CerS can be regulated by phos-
phorylation, by homo- or heterodimerization, and by inter-
action with fatty acid elongase, ELOVL1 (10–12). The CerS
are highly homologous proteins and reside in the endoplas-
mic reticulum where they have access to their two sub-
strates, sphinganine and acyl-CoA esters.
A number of attempts have beenmade tomodel flux through
the SL biosynthetic pathway (13, 14). In contrast, experimental
analysis of flux is limited to studies showing that the availability
of fatty acids and serine can affect ceramide synthesis. This
indicates that SL flux is coupled to other metabolic routes
including synthesis and degradation of storage lipids like tria-
cylglycerols (15, 16), fatty acid elongation, and fatty acid avail-
ability (12). Interestingly, acyl-CoA synthetase 5 (ACSL5) has
recently been functionally coupled to ceramide synthesis via
interaction with ceramide synthases (17). Acyl-CoA esters are
generated in the cytosol via the action of acyl-CoA synthetases
(18) and subsequently sequestered by high-affinity acyl-CoA-
binding domain proteins (ACBDs), which determine the meta-
bolic routes and regulatory properties of acyl-CoA esters. The
ACBDs comprise a highly conserved multigene family of intra-
cellular lipid-binding proteins (19). Expression analyses con-
firm that ACBD1, also commonly known as ACBP, is by far
the most abundantly expressed paralog (19). Recent genetic
studies show that loss of ACBP in Saccharomyces cerevisiae and
Caenorhabditis elegans abrogates fatty acid chain elongation
and SL synthesis, resulting in compromised plasma membrane
integrity and membrane function (20).5
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We now show for the first time that ACBP potently activates
CerS2 and CerS3 activity via direct interaction, and we show
that ACBP ablation has deleterious effects on SL levels in
mouse testis. We suggest that this novel interaction acts as a
critical mode of regulation of very-long-chain ceramide syn-
thesis and as a putative site of interconnection between path-
ways of glycerolipid and SL synthesis. Hence, we suggest that
the interaction between ACBP and CerS is important for
directional channeling of acyl moieties in various cellular
states.
Results
ACBP stimulates CerS activity
Ceramide synthases catalyze the N-acylation of sphinganine
using acyl-CoA esters as substrate. By virtue of its ability to bind
acyl-CoA esters, we speculated that CerS activity is determined
by the availability of acyl-CoA esters. We therefore assayed
CerS activity in homogenates of HEK293T cells overexpressing
each of the six CerS isoforms in the presence or absence of
ACBP. These studies showed that recombinant ACBP potently
Figure 1. ACBP stimulates CerS2 and CerS3 activity in vitro. Homogenates were prepared from HEK293T cells overexpressing Cers1 (A), CerS2 (B),
CerS3 (C), CerS4 (D), CerS5 (E), or CerS6 (F) or a catalytic inactive form of CerS3 (W15R) (G). CerS activity was determined using C18:0-CoA (A), C24:1-CoA (B),
C26:0-CoA (C, G, and H), C20:0-CoA (D), and C16:0-CoA (E and F), respectively, in the presence of increasing amounts of ACBP. H, CerS3 activity was assayed
in the presence of increasing amounts of C26:0-CoA in the presence or absence of 1 nM recombinant ACBP. The results are mean values S.D., n 3 for
A–G, and n  6 for H.
ACBP is required for very-long acyl chain ceramide synthesis
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stimulates both CerS2 and CerS3 activity. In the absence of
ACBP, CerS2 activity was 82  7 pmol/mg/min, which
increasedmore than 2-fold in the presence of as little as 0.25 nM
ACBP (Fig. 1B). In the absence of ACBP, CerS3 activity was
16.0  5.4 pmol/mg/min, which increased nearly 7-fold upon
addition of ACBP (Fig. 1C). ACBP had no effect on the activity
of the other CerS isoforms (Fig. 1) and did not affect the activity
of a catalytic inactive form of CerS3 (Fig. 1). CerS activity
increased in a biphasic manner (Fig. 1) upon increasing C26:0-
CoA levels while keeping ACBP levels constant, indicating that
CerS3 has both low- and high-affinity binding components.
Furthermore, the Vmax of CerS3 toward sphinganine was
increased from 55 to 235 pmol/mg/min in the presence of
ACBP (Fig. 2).
To further substantiate the finding that ACBP stimulates
CerS activity, HEK293T cells were co-transfected with ACBP
and CerS2 or CerS3. The activities of both CerS2 and CerS3
significantly increased upon co-transfection to levels that were
comparablewithCerS activity upon addition of purified recom-
binant ACBP to cell lysates (Fig. 3).Moreover, because ACBP is
a highly abundant cytosolic protein, we hypothesized that addi-
tion of cytosol would stimulate CerS3 activity. Indeed, we dem-
onstrated that both low speed (10,000  g) and high-speed
(100,000  g) supernatants from wild-type mouse liver tissue
stimulate CerS3 activity in vitro (Fig. 4). Importantly no stimu-
lation of CerS3 activity was observed when using cytosol from
an ACBP/ mouse, confirming that ACBP is the main factor
in liver cytosol capable of activating CerS. This was further
supported by the dose-dependent stimulation of CERS activity
using cytosol from heterozygous ACBP/mouse liver result-
ing in 50% activity relative to wild-type cytosol (Fig. 4).
Figure2.ACBP increasesCerS3activity.Homogenateswereprepared from
HEK293T cells overexpressing CerS3, and CerS3 activity was determined
using C26:0-CoA in the presence of increasing amounts of sphinganine. The
results are shown as means S.D., n 3.
Figure 3. Co-expression of ACBP in HEK293T cells increases CerS2 and CerS3 activity. CerS2-HA (A) or CerS3-HA (B) were co-expressed in HEK293T cells
with Flag-tagged ACBP, and CerS2 or CerS3 activity was assayed. CerS2 or CerS3 activity was also assayed in cell lysates from cells transfected with CerS2 or
CerS3 after the addition of purified, recombinant ACBP. The data shown represent means S.D., n 3. Statistical analyses were performed using unpaired t
test. *, p 0.05; **, p 0.01; ***, p 0.001; ****, p 0.0001.
Figure 4. CerS3 activity is activated by high-speed cytosol.Homogenateswere prepared fromHEK293T cells overexpressing CerS3, and CerS3 activity was
determined using C26:0-CoA after addition of purified recombinant ACBP or liver 10,000 g cytosol (A) or liver 100,000 g cytosol (B) prepared fromACBP
/,
ACBP/, or ACBP/mice. The data shown represent means S.D., n 3. The statistical analyses were performed using unpaired t test. *, p 0.05; **, p
0.01; ***, p 0.001; ****, p 0.0001.
ACBP is required for very-long acyl chain ceramide synthesis
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Together, these observations demonstrate that the activity of
both CerS2 andCerS3 is highly regulated by substrate availabil-
ity mediated by ACBP.
ACBP ablation alters CerS activity and the sphingolipidome of
mouse testis
Because ACBP potently stimulates CerS2 and CerS3 activity
in vitro, we examined CerS2 and CerS3 activities in testis from
ACBP depleted (ACBP/) mice. Consistently, we observed
significantly reduced CerS2 and CerS3 activity in testis from
ACBP/ mice (Fig. 5), which was not due to altered Cers
mRNA expression (Fig. 6). This prompted us to examine the
sphingolipidome inACBPvmice. Thus, we analyzed the SL pro-
file of testis fromACBP/ and ACBP/mice by ESI-MS/MS
and found significant changes in ceramide, dihydroceramide,
glucosylceramide, dihydroglucosylceramide, sphingomy-
elin, and dihydrosphingomyelin levels (Fig. 7). CerS2 utilizes
primarily C22-C24-CoAs and C18-CoA to a very minor extent
(21), whereas CerS3 mainly uses C26:0-CoA. Reduction in
CerS2 and CerS3 activities might cause changes in levels of SLs
containing other acyl chain lengths as we observe, because of
altered dimer formation, which can significantly affect cer-
amide formation (10).
Activation of CerS3 requires ligand binding to ACBP
ACBP binds saturated and unsaturated C14-C22 acyl-CoA
esterswith an affinity of 1–15 nM in a one-to-one bindingmode,
whereas free CoA binds with amuch lower affinity (KD of 2M)
(22–24). The present finding that ACBP activates CerS2 and
CerS3 suggests that ACBP can also bind very-long-chain acyl-
CoA esters. Using gel shift assays under non-denaturing condi-
tions, we observed that C12:0-C26:0-CoAs alter the mobility of
ACBP (Fig. 8A), arguing that ACBP binds these acyl-CoA
esters, although C12 and C26-CoA is bound with lower affinity
than the other acyl-CoA esters.
To test whether ligand binding to ACBP is required for
CerS3 activation, we examined the effect of a panel of ACBP
mutants, which do bind acyl-CoA (Ref. 23 and Fig. 8B), on
CerS3 activity. CerS3 activity was not stimulated by ACBP in
which Tyr28, Lys32 or Lys54 were mutated to alanine, which
all interact with the 3	-phosphate on CoA and are required
for ligand binding (Fig. 9). Moreover, altering the interaction
between ACBP and the -end of the acyl-chain or the ade-
nine ring by altering Leu-25 or Phe-5 to alanine, respectively,
also abolishes the activating properties of ACBP (Fig. 9). Liv-
er-type fatty-acid-binding protein-1 (FABP1), which also
binds acyl-CoA esters and is highly abundant in liver (25),
did not activate CerS3 (Fig. 9), which further substantiates
that activation of ceramide synthase activity by ACBP is
specific.
CerS interacts with ACBP
Our results clearly demonstrate that CerS2 and CerS3 are
both activated by ACBP, suggesting that ACBP specifically tar-
get acyl-CoA esters to CerS2 or CerS3 via direct interaction.
We were unable to detect such interactions by gel-shift assays
or by co-immunoprecipitation with or without cross-linking
(not shown), likely because of the transient nature of this puta-
tive interaction. We therefore used a proximity ligation assay
(PLA) (26) in which we co-expressed CerS3-HA and ACBP-
FLAG in HEK293T cells and were able to detect an interaction
between CerS3 and ACBP (Fig. 10). Consistent with the intra-
cellular localization of CerS3, the CerS3-ACBP interaction
localized to the perinuclear/ER (Fig. 10, A and B). We demon-
strate that ACBP also interacts with othermembers of the CerS
family (Fig. 10B), even though their activity is notmodulated by
ACBP (Fig. 1) and also interacts with CerS2 and CerS3 even
though they are catalytic inactive (Fig. 10C). Neither deletion of
the HOX domain nor the C terminus of CerS2 affected the
interaction with ACBP (results not shown).
Discussion
In the present study we show for the first time that CerS
interact with and are regulated by ACBP, suggesting a novel
Figure 5. Loss of ACBP in mice reduces CerS activity in vivo. CerS2 and
CerS3 activities were determined in homogenates from testes from either
ACBP/mice (black bars) or ACBP/mice (gray bars) using C22:0-CoA and
C26:0-CoA as substrates, respectively. The values are mean values S.D., n
3. Statistical analyses were performed using unpaired t test. **, p 0.01.
Figure 6. Cers1–6 expression is unaffected in testes of ACBP/mice. Total RNAwas isolated from testis fromACBP/ (black bars) or ACBP/mice (gray
bars), andexpression levels ofCers1–6weredeterminedbyquantitativePCR. Thedata shownaremeanvaluesS.D.,n9. Statistical analyseswereperformed
using unpaired t test.
ACBP is required for very-long acyl chain ceramide synthesis
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mode of regulating sphingolipid synthesis. Despite the im-
portance of ceramides and other sphingolipids as struc-
tural entities and as signaling molecules, the molecular
mechanisms governing their synthesis remain unclear. In
mammals, regulation of de novo ceramide synthesis may
involve a complex balance between the six CerS isoforms
because CerS activity can be modulated by reversible di-
merization (10). Thus, different CerS isoforms physically
interact, and the co-expression of one particular isoform can
modulate the activity of another. Although the mechanisms
Figure 7. Ablation of ACBP affects the testis sphingolipidome. LC-ESI-MS/MS analysis of ceramide (A), dihydroceramide (B), glucosylceramide (C), dihydro-
glucosylceramide (D), sphingomyelin (E), dihydrosphingomyelin (F), and sphingoidbases (G) from testis fromACBP/mice (black bars) or ACBP/mice (gray
bars). Thevalues representmeansS.D.,n3. Statistical analyseswereperformedusingunpaired t test. *,p0.05; **,p0.01; ***,p0.001; ****,p0.0001.
ACBP is required for very-long acyl chain ceramide synthesis
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driving dimerization remains unresolved, it is likely to be
dynamic because pharmacologic stimulation of ceramide
synthesis leads to an increase in CerS dimerization (10, 27).
Accordingly, the recently reported transcriptional and post-
transcriptional regulation of CerS expression (28) may con-
tribute to their dimerization and activity. Moreover, sphin-
gosine-1-phosphate specifically inhibits CerS2 activity in
vitro via a regulatory site, indicating an important regulatory
interplay between sphingolipid metabolites (21).
The fact that CerS2 and CerS3 interact with and are regu-
lated by ACBP suggests that these proteins might form a func-
tional complex that drives ceramide synthesis. It is also inter-
esting to note that ELOVL1 interacts with CerS2, suggesting
that synthesis of C24-CoA by ELOVL1 is coordinated with
the utilization of C24-CoA by CerS2 for ceramide production
(12). We therefore speculate that CerS2, ELOVL1 and ACBP
form a functional platform, which promotes coordinated
and directional synthesis of very-long-chain acyl-CoA esters
and ceramides. As a consequence, this interaction might
determine the flux through the de novo ceramide synthesis
pathway. To this end, generation of acyl-CoA esters by
ACSL5 has recently been functionally coupled to ceramide
synthesis (17), suggesting that ACSLs also could be part in
such platforms. Notably, serine palmitoyl transferase, which
catalyzes the first and rate-limiting step in sphingolipid syn-
thesis, is also regulated by specific protein interactions by
reversibly forming a SPOTS (SPT, ORM1/2, TSC3, SAC1)
complex with a family of conserved Orm proteins, the serine
palmitoyltransferase accessory subunit Tsc3, and the phos-
phoinositide phosphatase Sac1 (29, 30). However, even
though CerS4–6 also interact with ACBP, their (and CerS1)
kinetics are not affected by increasing levels of ACBP. Simi-
larly, CerS2 also interacts with ELOVL1–7, although CerS2
only affects ELOVL1 activity (12). As the acyl chain length
increases, the solubility of acyl-CoA esters in aqueous solutions
decreases rapidly. Thus, whereas CerS1 and CerS4–6 all are
characterized by having a preference for long-chain acyl-CoA
esters, CerS2 and CerS3 both prefer very-long-chain acyl-CoA
(31). Thus, we speculate that ACBP interacts with all the CerS
to maintain a critical level of available acyl-CoA substrates,
which is particularly important for CerS2 and CerS3.
Further kinetic analyses of CerS3 activation by ACBP
revealed a biphasic saturation profile suggesting the presence of
both low- andhigh-affinity binding sites. Suchakinetic profile has
beenobservedforanumberofotherenzymes,e.g.naproxendemeth-
ylation by CYP2C9 (32, 33), CYP3A4-mediated metabolism of
naphthalene (32), and 7-ethoxycoumarin O-deethylation and
aminopyrineN-demethylation by NADPH-P450 reductase (34).
Even though the level of FABP1, which also binds acyl-CoA
esters, is 10-fold higher than ACBP in liver, which also con-
tains other acyl-CoA-binding domain containing proteins (19),
we show that ACBP is the primary factor in liver cytosol that
stimulates CerS activity in vitro. This and the fact that ACBP
mutants, incapable of binding ligand, cannot stimulate cer-
amide synthase activity, underline the suggestion that ACBP
specifically channels acyl-CoA esters for activation of CerS2
and CerS3. Accordingly, ablation of ACBP in mice testis, in
which both CerS2 and CerS3 are highly expressed (21),
results in global alterations in ceramide and sphingomyelin
levels. This, however, does not affect reproduction of ACBP-
null mice (35). We previously reported that loss of ACBP in
mice impairs the epidermal barrier function resulting in heat
and water loss (36). Because synthesis of ceramides contain-
ing ultra-very-long-chain acyl chains generated by CerS3 in
keratinocytes are required for the integrity of the epidermal
barrier in both mice and humans (37–39), we speculate that
the impaired epidermal barrier in ACBP knock-out mice
might be due to reduced levels of ceramides produced by
CerS3 in the absence of ACBP.
In conclusion, we have identified a novel mode of regulating
CerS2 and CerS3 activity in vivo via an interaction with ACBP.
The present work and the genetic mice models that we have
available provide an excellent framework to further delineate
how ceramide synthases are regulated in vivo by acyl-CoA-
binding proteins and how this interaction affects mammalian
physiology. By analogy to other lipid binding proteins involved
in intra- and intercompartmental trafficking of sphingolipids
Figure 8. ACBP binds long-chain and very-long-chain acyl-CoA esters.
Left panel, recombinant rat ACBP was incubated with the indicated satu-
rated acyl-CoA (1:1 molar ratio); apo- and holo-ACBP were subsequently
separated by native gel electrophoresis; and protein bands were visual-
ized by Coomassie staining. Right panel, recombinant rat ACBP (WT) or
ACBP Y28Awere incubatedwith C16:0-CoA and subsequently separated by
native gel electrophoresis, and protein bands were visualized by Coomas-
sie staining.
Figure 9. CerS3 activity is activated by ACBP and depends on ligand binding to ACBP.Homogenates were prepared from HEK293T cells overexpressing
CerS3 and CerS3 activity was determined using C26:0-CoA after addition of purified recombinant ACBP or amutated form of ACBP (A), which binds ligandwith
very lowaffinity, or purified recombinant liver FABP1 (B). The values are shownasmeans S.D.,n3. Statistical analyseswereperformedusingunpaired t test.
*, p 0.05; **, p 0.01; ***, p 0.001; ****, p 0.0001.
ACBP is required for very-long acyl chain ceramide synthesis
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like FAPP2 andCERT (40), we anticipate thatACBP constitutes
a new regulatory lipid binding protein, which plays a central
role in the sphingolipid network and is therefore important in
our understanding of human diseases triggered by altered sph-
ingolipid metabolism.
Experimental procedures
Materials
D-Erythro-[4,5-3H]sphinganine was synthesized as described
(41). Fatty acyl-CoAs, sphinganine, lipid standards for TLC, and
internal standards for LC-ESI-MS/MS were from Avanti Polar
Figure 10. CerS and ACBP interact in situ. FLAG-tagged ACBP was co-expressed in HEK293T cells together with HA-tagged CerS2 or CerS3 (A), the indicated
HA-tagged CerS (B), and HA-tagged wild-type and mutated (both W15R) forms of CerS2 or CerS3 (C). PLA using primary antibodies against HA and FLAG tags and
secondaryantibodies carryingPLAprobeswereapplied tovisualize theACBP-CerS interaction.DAPIwasused todetectnuclei.Scalebars, 10or20m(ACBP/CerS2 in
B). Controlswere cells transfectedwith empty plasmids alone or in combinationwith either ACBPor CerS3 plasmids. Other controls received either only oneprimary
antibodyor none.D,Westernblots showexpressionof FLAG-taggedACBPandHA-taggedCerS inHEK293T cells transfectedwith the indicatedplasmid.GAPDHwas
used as loading control. The arrowsmark the CerS. 2m and 3m indicate cells expressing CerS2W15R and CerS3W15R, respectively.
ACBP is required for very-long acyl chain ceramide synthesis
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Lipids (Alabaster, AL). Silica gel 60 TLC plates were fromMerck.
All solventswere of analytical grade andwere fromBiolab (Jerusa-
lem, Israel). Defatted bovine serum albumin and a protease inhib-
itor mixture were from Sigma-Aldrich.
Mice
Acbp knock-out mice have been described previously (35,
36). The mice were housed under standard conditions (36).
Animal experiments and breeding of transgenic mice were
approved by the Danish Animal Experiment Inspectorate. Tis-
sues were dissected and processed according to previously
described procedures (36).
Cell culture
HEK293T cells were cultured in Dulbecco’s modified Eagle’s
medium (Gibco) supplemented with 10% fetal calf serum, 100
IU/ml penicillin, and 100 g/ml streptomycin. HEK293T cells
were transfected with human CerS with an HA tag at the C
terminus (CerS-HA) and/or murine ACBP (ACBD1) with a
Flag tag at the C terminus using a jetPEIaTM, DNA in vitro
transfection reagent (Polypus transfection) (8 g of DNA/
10-cm culture dish). 48 h after transfection, the cells were col-
lected by trypsinization and stored at80 °C.
Expression and purification of recombinant rat ACBP
Protein expression and purification of rat ACBP was per-
formed as described (42). Selected residues in rat ACBP were
replaced with alanine by site-directed mutagenesis (43).
CerS assays and SLmeasurements
CerS was assayed in homogenates as described using [4,5-
3H]sphinganine, 15 M sphinganine, 20 M defatted bovine
serum albumin, and 50M fatty acyl-CoA (Avanti Polar Lipids,
Alabaster, AL) (44). For CerS1 and CerS4 assays 150 g of pro-
tein was used; for CerS2, CerS5, and CerS6 100 g of protein
was used; and for CerS3 assays 250 g of protein was used.
When the effects of high-speed cytosols on CerS activity were
examined, 6 g of cytosol protein was added for each l assay.
SL levels were measured by ESI-MS/MS using a PE-Sciex API
3000 triple quadrupole mass spectrometer and an ABI 4000
quadrupole-linear ion trap mass spectrometer (45, 46).
Proximity ligation assay
The interaction between ACBP and CerS was examined by
PLA in HEK293T cells essentially as described previously (47).
Briefly, 0.48 g of DNA was mixed with 1 g of polyethyleni-
mine, diluted with 20l of DMEM, and incubated for 10min at
room temperature. The cells were grown to 90–95% conflu-
ence in a 10-cm Petri dish, detached by incubation with 500 l
of trypsin, and neutralized with 5.5 ml DMEM, mixed with the
transfectionmixture and seeded into 16 chambered cover glass
(C37000; Thermo). The cells were incubated as described
above for 48 h. DMEM was aspirated, the cells were washed
with PBS, the chambers were removed, and the cells were fixed
with 4% paraformaldehyde in H2O for 10 min at room temper-
ature. The cells were washed three times for 5 min each in PBS
in a 10-cm Petri dish with gentle agitation. The cells were per-
meabilized with 0.5% Triton X-100 in PBS for 10 min, followed
by three washes in 0.05% Tween 20 in TBS for 5 min each in a
10-cm Petri dish with gentle agitation. The cells were blocked
with 1 drop of Duolink in situ blocking solution (DUO82007;
Sigma-Aldrich) for 1 h at 37 °C in a humidity chamber. The cells
were incubated with 40 l of primary antibodies: anti-DDK
(TA50011; Origene) and anti-HA (H6908; Sigma-Aldrich), 1
g/ml diluted in Duolink antibody diluent (DUO82008; Sig-
ma-Aldrich) for 1 h at 37 °C in a humidity chamber. The cells
were washed for 2 min followed by two 10-min washes in
Duolink in situwash buffer A (DUO82047; Sigma-Aldrich) in
a 10-cm Petri dish with gentle agitation and incubated with 40
l of Duolink in situ PLA probes, anti-rabbit (DUO82002;
Sigma-Aldrich) or anti-mouse (DUO82004; Sigma-Aldrich)
diluted 5 in Duolink antibody diluent (DUO82008; Sigma-
Aldrich) for 1 h at 37 °C in a humidity chamber. The cells were
washed for 2 min followed by two 10-min washes in Duolink
in situwash buffer A in a 10-cmPetri dish with gentle agitation.
PLA probes were ligated by incubation with 40 l of Duolink
in situ ligase diluted 1:40 in Duolink in situ ligation
(DUO82009; Sigma-Aldrich) for 30 min at 37 °C in a humidity
chamber followed by two washes for 2 min in Duolink in situ
wash buffer A in a 10-cm Petri dish with gentle agitation. PLA
probes were amplified by incubation with 40 l of Duolink in
situ amplification Red diluted 1:40 in 1 Duolink in situ liga-
tion (DUO82011; Sigma-Aldrich) for 100 min at 37 °C in a
humidity chamber and washed twice for 10 min in Duolink in
situwash buffer B (DUO82048; Sigma-Aldrich) in a 10-cmPetri
dish with agitation (30 rpm). The cover slides were dipped in
10 diluted Duolink in situ wash buffer B (DUO82048; Sig-
ma-Aldrich), the silicone membrane around the cells was
removed, and the cover slides were mounted on microscopy
slides with Duolink in situ mounting medium with DAPI
(DUO82040; Sigma-Aldrich). Florescent signals were visual-
ized at ambient temperature on a Leica TCS SP8X confocal
microscopewith a hybrid detector using aHCXPLAPO100/
1.40 oil objective using Leica Application Suite software. The
images were processed using ImageJ (48).
RNA isolation and real-time PCR
Isolation of total RNA and determination of mRNA levels
by real-time PCR were carried out as described (36). TFIIB ex-
pression was used for normalization. The following real-time
primers were used: TfIIb forward, 5	-GTT CTG CTC CAA
CCT TTG CCT-3	; TfIIb reverse, 5	-TGT GTA GCT GCC
ATC TGCACT T-3	; CerS1 forward, 5	-GCC ACCACACAC
ATC TTT CGG-3	; CerS1 reverse, 5	-GGA GCA GGT AAG
CGC AGT AG-3	; CerS2 forward, 5	-AGA GTG GGC TCT
CTG GAC G-3	; CerS2 reverse, 5	-CCA GGG TTT ATC CAC
AGT GAC-3	; CerS3 forward, 5	-CCT GGC TGC TAT TAG
TCT GAT G-3	; CerS3 reverse, 5	-CTG CTT CCA TCC AGC
ATA GG-3	; CerS4 forward, 5	-CTG TGG TAC TGT TGT
TGC ATG AC-3	; CerS4 reverse, 5	-GCG CGT GTA GAA
GAAGACTAAG-3	; CerS5 forward, 5	-TGGCCAATTATG
CCA GAC GTG AG-3	; CerS5 reverse, 5	-GGT AGG GCC
CAA TAA TCT CCC AGC-3	; CerS6 forward, 5	-GCA TTC
AAC GCT GGT TTC GAC-3	; and CerS6 reverse, 5	-TTC
AAG AAC CGG ACT CCG TAG-3	.
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Western blotting
Transfected HEK293T cells were harvested in SDS lysis
buffer and protein extracts were prepared as described in Ref.
36. The protein concentration was determined using a Pierce
BCA protein assay kit, followed by SDS-PAGE protein separa-
tion, blotting, and ECL as described in Ref. 36. The following
antibodies were used: anti-HA (H6908; Sigma), anti-DDK
(TA50011; Origene), anti-GAPDH (sc-25778; Santa Cruz), and
horseradish peroxidase-conjugated anti-rabbit and anti-mouse
antibodies (W4011 and W4021; Promega).
Statistics
Statistical analysis was performed using the Student’s t test,
and differences among groups were considered significant for
p 0.05 (*), p 0.01 (**), p 0.001 (***), and p 0.0001 (****).
Author contributions—N. S. F. performed CerS assays, H. E. per-
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